DIAGNOS (ADK) News Today C$0.28 +0.01 (+1.79%) As of 10:07 AM Eastern Add Compare Share Share Headlines Stock AnalysisChartEarningsInsider TradesBuy This Stock ADK Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period DIAGNOS Inc.: DIAGNOS Files FDA Pre-Submission for its CARA System: Strategic Entry into the U.S. Optometry Market with Support from ORA LLCJuly 16, 2025 | finanznachrichten.deDIAGNOS Inc. (DGNOF) Latest Press Releases & Corporate News - Yahoo Finance CanadaJune 27, 2025 | ca.finance.yahoo.comDiagnos taps Allele for capital markets, social media servicesMay 25, 2025 | investing.comDiagnos’ CARA System License Application Advances with Health CanadaApril 9, 2025 | msn.comDIAGNOS Opens First US Office in FloridaMarch 31, 2025 | markets.businessinsider.comDIAGNOS Second Quarter 2025 Earnings: Revenues DisappointNovember 23, 2024 | finance.yahoo.comDIAGNOS Announces Cross-listing of its Common Shares on the Frankfurt Stock ExchangeNovember 12, 2024 | finance.yahoo.comDIAGNOS Inc.: DIAGNOS Announces Voting Results of Meeting of ShareholdersOctober 1, 2024 | finanznachrichten.deADK:CA DIAGNOS Inc.September 21, 2024 | seekingalpha.comDIAGNOS First Quarter 2025 Earnings: EPS Beats Expectations, Revenues LagAugust 23, 2024 | finance.yahoo.comGot $1,000? 2 Stocks to Buy Now While They’re on SaleFebruary 23, 2024 | ca.finance.yahoo.comDIAGNOS recognized as a Top TSX Venture Exchange CompanyFebruary 21, 2024 | finance.yahoo.comClosing Bell: Diagnos Inc flat on Thursday (ADK)February 9, 2024 | theglobeandmail.comDiagnos appoints Yves-Stéphane Couture as chief operating officerJanuary 16, 2024 | msn.comDIAGNOS Appoints New Chief Operating OfficerJanuary 16, 2024 | finance.yahoo.comCanadian Investment Regulatory Organization Trading Halt - ADKDecember 8, 2023 | finance.yahoo.comDIAGNOS Inc. (ADK.V)November 18, 2023 | finance.yahoo.comThe last government shutdown deadline ousted the House speaker. This week's showdown could be easierNovember 14, 2023 | msn.comClosing Bell: Diagnos Inc flat on Friday (ADK)November 4, 2023 | theglobeandmail.comDiagnos Laboratorium Utama PT Tbk (DGNS)October 24, 2023 | investing.comDIAGNOS AI Retina Analysis is being deployed across Canada's Largest Specialist Care Provider in Diabetes & EndocrinologyOctober 7, 2023 | stockhouse.comDIAGNOS AI Retina Analysis is being deployed across Canada’s Largest Specialist Care Provider in Diabetes & EndocrinologyOctober 5, 2023 | finance.yahoo.comDiagnos, Appulse, Bedford at 52-Week HighsSeptember 8, 2023 | baystreet.caClosing Bell: Diagnos Inc down on Friday (ADK)July 15, 2023 | theglobeandmail.comEchelon Wealth Partners Believes Diagnos (ADK) Won’t Stop HereJuly 6, 2023 | markets.businessinsider.comDIAGNOS and IRIS, The Visual Group strengthen partnership with the launch of “IRIS-ai powered by DIAGNOS”May 17, 2023 | finance.yahoo.comTMX, Arrow, CPKC at 52-Week Highs on NewsMay 15, 2023 | baystreet.caMichael J. Fox: Do you have Parkinson's? New test is 'breakthrough' in diagnosing disease.May 11, 2023 | usatoday.comClosing Bell: Diagnos Inc up on Wednesday (ADK)May 4, 2023 | theglobeandmail.comClosing Bell: Diagnos Inc up on Monday (ADK)May 2, 2023 | theglobeandmail.comClosing Bell: Diagnos Inc up on Thursday (ADK)April 28, 2023 | theglobeandmail.comClosing Bell: Diagnos Inc up on Tuesday (ADK)April 19, 2023 | theglobeandmail.comDIAGNOS and ÉTS Unveil a Method to Adapt Deep Learning Algorithms According to the Diversity of ContextsFebruary 28, 2023 | finance.yahoo.comDIAGNOS Provides Additional Information to the Closing of Private PlacementDecember 15, 2022 | finance.yahoo.comADK.V - Diagnos Inc | Stock Price & Latest News | ReutersNovember 5, 2022 | reuters.comDIAGNOS Enters the Retinal Diagnostics Market With its New 3D Image Analysis TechnologyOctober 27, 2022 | finance.yahoo.comDIAGNOS Receives Regulatory Approval from the Costa Rica Health Agency for its Artificial Intelligence Enabled Pathology Detection SystemsAugust 18, 2022 | finance.yahoo.comDIAGNOS Continues Expansion in Canada with Kick-off of Services in Endocrinology Clinics with Distribution Partner Labtician OphthalmicsJuly 27, 2022 | finance.yahoo.comDIAGNOS Announces the Deployment of its Age-Related Macular Degeneration Detection Application Into the Optometry Clinics of IRIS, The Visual GroupJune 7, 2022 | finance.yahoo.comDIAGNOS and the CHUM are launching the testing phase of autonomous artificial intelligence solutions dedicated to diabetic retinopathy screeningMay 26, 2022 | stockhouse.comEx-attorney general Eric Holder on gerrymandering: 'Republicans have to cheat' in electionsMay 11, 2022 | yahoo.comDIAGNOS Successfully Completes ISO / MDSAP AuditFebruary 10, 2022 | finance.yahoo.comDIAGNOS Delivers World Class Results in the MICCAI2021 Contest: GAMMAOctober 28, 2021 | nz.finance.yahoo.comDIAGNOS Announces Date of Annual General and Special Meeting of ShareholdersAugust 17, 2021 | ca.finance.yahoo.comDIAGNOS signs Memorandum of Understanding with Essilor International.August 16, 2021 | stockhouse.com Get DIAGNOS News Delivered to You Automatically Sign up to receive the latest news and ratings for ADK and its competitors with MarketBeat's FREE daily newsletter. Email Address ADK Media Mentions By Week ADK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ADK News Sentiment▼0.000.47▲Average Medical News Sentiment ADK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ADK Articles This Week▼00▲ADK Articles Average Week Get DIAGNOS News Delivered to You Automatically Sign up to receive the latest news and ratings for ADK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Vitalhub News kneat.com News Oncolytics Biotech News SugarBud Craft Growers News Quipt Home Medical News Medicenna Therapeutics News Aptose Biosciences News Sernova News Covalon Technologies News Medexus Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CVE:ADK) was last updated on 8/12/2025 by MarketBeat.com Staff From Our PartnersWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredThe stealth altcoin the financial world is underestimatingThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredMy shocking meeting in Washington, D.C.After a shocking discovery in D.C., Jeff Brown is revealing: President Trump’s “Project MAFA” Get a look...Brownstone Research | SponsoredBig Changes Coming in August — Is Your IRA Ready?Banks aren’t waiting for the headlines to catch up. They’ve already started moving their wealth out of pape...Reagan Gold Group | Sponsored#1 Pre-IPO Opportunity For 2025 [Take Action Now!]James Altucher has scored 37X and even 60X returns on past pre-IPO deals. But now he says a much bigger opport...Paradigm Press | SponsoredSilver Demand Is Exploding—and Supply Can’t Keep UpElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DIAGNOS Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DIAGNOS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access